Filing summary
Picard Medical, Inc. (NYSE American: PMI) filed a Form 8-K reporting a corporate governance change approved October 7, 2026. The filing does not report operating or financial results.
Business context and reporting period
The report covers an event dated October 7, 2026. The company is incorporated in Delaware and identified as an emerging growth company.
Material change
Effective immediately on October 7, the board amended Section 9 of the company’s bylaws, reducing the quorum for stockholder meetings from a majority of the voting power of shares entitled to vote to 33⅓% of that voting power. The filing states the revised threshold complies with Delaware law and NYSE American requirements. The amendment is included as Exhibit 3.1.
Financial metrics and outlook
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, guidance, or other financial metrics. It includes no management outlook or financial commentary.
Investor points to verify
- Review Exhibit 3.1 for the complete amendment and any related procedural details.
- Consider how the lower quorum threshold could affect stockholder meeting participation and voting outcomes; the filing does not describe a specific expected effect.